US based Analysis Report on Healthcare, Regulatory and Reimbursement Landscape in Major Developed Pharmaceutical Markets

Transcription

US based Analysis Report on Healthcare, Regulatory and Reimbursement Landscape in Major Developed Pharmaceutical Markets
US based Analysis Report on Healthcare,
Regulatory and Reimbursement Landscape
in Major Developed Pharmaceutical Markets
“Country Focus: Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential
source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the
US. It identifies key trends in the country’s healthcare market and provides insights into its
demographic, regulatory, and reimbursement landscape and healthcare infrastructure.
Most importantly, the report, “Country Focus: Healthcare, Regulatory and Reimbursement Landscape US” provides valuable insights into the trends and segmentation of its pharmaceutical and medical
devices markets. It uses data and information sourced from proprietary databases, secondary research,
and in-house analysis by industry experts.
Browse Detailed Toc, Tables, Figures, Charts and Companies Mentioned in Healthcare, Regulatory and
Reimbursement Landscape – US Report at - http://www.absolutereports.com/countryfocus-healthcareregulatory-and-reimbursement-landscape-us-10075422
The population of the US in 2013 amounted to 316.1 million, having grown at a Compound Annual
Growth Rate (CAGR) of 0.8% from 2008. The country’s increasingly elderly population and corresponding
increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical market,
which was worth $326.9 billion in 2008, a value that is expected to have reached $548.4 billion by 2020
at a CAGR of 4.4%. Approximately 86.6% of the US population has healthcare coverage, which has
helped to create an efficient healthcare system. New initiatives taken by the Food and Drug
Administration (FDA) have strengthened the review and approval process. The value of the US medical
device market was $116.2 billion in 2008, and is expected to register a CAGR of 5.0% to reach an
estimated $209.7 billion in 2020.
Ask for Discount on Healthcare, Regulatory and Reimbursement Landscape – US Report at –
http://www.absolutereports.com/enquiry/request-discount/10075422
+1 408 520 9750
www.absolutereports.com
Scope of this Report:
The report provides information on the healthcare, regulatory, and reimbursement landscape in the US,
and includes - An overview of the pharmaceutical and medical device markets, including market size, segmentation,
and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceuticals market: Pfizer, Merck,
Novartis, Sanofi and Abbott; and profiles and SWOT analyses of the major players in the medical device
market: Medtronic, DePuy, Siemens Healthcare, Abbott Laboratories, and Stryker etc.
Request sample PDF of this report at - http://www.absolutereports.com/enquiry/requestsample/10075422
Reasons to buy:
This report will enhance your decision-making capability by allowing you to - Develop business strategies by understanding the trends shaping and driving the US healthcare
market.
- Drive revenue by understanding the key trends, reimbursement and regulatory policies,
pharmaceutical market segments, and companies likely to affect the US healthcare market in the future.
About Absolute Report: Absolute Reports is an upscale platform to help key personnel in the business
world in strategizing and taking visionary decisions based on facts and figures derived from in depth
market research. We are one of the top report resellers in the market, dedicated towards bringing you
an ingenious concoction of data parameters.
Contact–
Mr. Ameya Pingaley
Absolute Reports
+1-408 520 9750
Email – [email protected]
Website: www.absolutereports.com
+1 408 520 9750
www.absolutereports.com

Similar documents

Medtronic plc, Bioventus LLC and Depuy Companies Dominate the UK Orthobiologics Market Report

Medtronic plc, Bioventus LLC and Depuy Companies Dominate the UK Orthobiologics Market Report The orthobiologics market in the UK is expected to be driven by patient demographics, the development of novel product designs, increasing patient awareness, increasing participation in sports related activities, and a rising incidence of road accidents. The data in the report is derived from dynamic market forecast models.

More information

France Orthopedic Prosthetics Procedure report to 2021, Market Shares, Research Report, Industry Analysis, Forecast Opportunity

France Orthopedic Prosthetics Procedure report to 2021, Market Shares, Research Report, Industry Analysis, Forecast Opportunity prosthesis is a functional replacement for an amputated or congenitally malformed or missing limb. Prosthetists are responsible for the prescription, design and management of a prosthetic device. In most cases, the prosthetist begins by taking a plaster cast of the patient's affected limb. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Lower Extremity Prosthetics and Upper Extremity Prosthetics.

More information

Ventricular Fibrillation: Global Industry Analysis, Trends, Market Demands, Segment and Forecast

Ventricular Fibrillation: Global Industry Analysis, Trends, Market Demands, Segment and Forecast Ventricular Fibrillation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India.

More information